CervoMed CRVO
NASDAQ CRVO
$2.33 +0.04 (+1.75%)
As of: Oct 21, 2026 · 3:07 PM EDT

CervoMed (CRVO) Receivables - Net (2011 - 2012)

Updated

CervoMed (CRVO) reported Receivables - Net of $71,667 for Q2 2012, up 34.0% from $53,500 a year earlier.

Analysis

CervoMed (CRVO) Receivables - Net (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 CervoMed 24.05 Mn -61.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 71,667.00
Sep 30, 2011 58,500.00
Jun 30, 2011 53,500.00
API Access

CervoMed Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CRVO&period=max&api_key=YOUR_API_KEY